Dr. Deborah Dunsire named new President and CEO of Lundbeck
Go back to Dr. Deborah Dunsire named new President and CEO of Lundbeck| Alexion Pharmaceuticals (NASDAQ: ALXN) | Delayed: 182.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $182.01 | 52 Week High | $193.45 | |||
| Open | $33.31 | 52 Week Low | $110.56 | |||
| Day High | $182.01 | P/E | 143.31 | |||
| Day Low | $182.01 | EPS | $1.27 | |||
| Volume | 71 | |||||
| ULTRAGENYX PHARM (NASDAQ: RARE) | Delayed: 14.50 -0.27 (1.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.77 | 52 Week High | $117.12 | |||
| Open | $14.87 | 52 Week Low | $46.52 | |||
| Day High | $14.94 | P/E | N/A | |||
| Day Low | $14.15 | EPS | $-1.97 | |||
| Volume | 4,272,118 | |||||
